Altai Protocol Library New Indication: Revumenib for Rel/Ref NPM1-Mutated AML U. Darda Bayraktar, MD 2025-10-26
Altai Protocol Library New Drug: Zanzalintinib for Metastatic Colorectal Cancer U. Darda Bayraktar, MD 2025-10-26
Altai Protocol Library New Indication: Quizartinib for Newly Diagnosed AML (FLT3-ITD Negative) U. Darda Bayraktar, MD 2025-10-23
Altai Protocol Library New Reference: Rituximab – Ibrutinib for Untreated Mantle Cell Lymphoma U. Darda Bayraktar, MD 2025-10-23
Altai Protocol Library New Reference: Neoadjuvant FOLFIRINOX vs. Chemoradiation for Pancreatic Cancer U. Darda Bayraktar, MD 2025-10-22
Altai Protocol Library New Indication: Lenvatinib + Pembrolizumab for Thymic Carcinoma U. Darda Bayraktar, MD 2025-10-22
Altai Protocol Library New Reference: Osimertinib with Platinum-Pemetrexed for Advanced EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2025-10-21
Altai Protocol Library New Indication: Pembrolizumab with Platinum-5FU for Advanced Penile Cancer U. Darda Bayraktar, MD 2025-10-20
Altai Protocol Library New Reference: Lenvatinib + Pembrolizumab for Melanoma U. Darda Bayraktar, MD 2025-10-20
Altai Protocol Library New Reference: Nivolumab + Cabozantinib for 1st Line RCC U. Darda Bayraktar, MD 2025-10-19
